Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor ModelPeila Chen, Carla L. Van Den Berg|PLoS ONE|2010Cited by 47
A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinibNancy D. Ebelt, Carla L. Van Den Berg|Oncotarget|2017Cited by 40
Transcription Factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stressMilad Soleimani, Carla L. Van Den Berg|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0